119
Archived articleThis is an archived article from 2022 - please note that any content within the article may be out of date.

Small Cap Value Report (Mon 21 Mar 2022) - STEM, SPSY, BBB

Good morning, it's Paul & Jack here with Monday's SCVR.

Agenda -

Jack's section:

Sthree (LON:STEM) - strong Q1 trading and ongoing investment in headcount. Conditions are positive and that might not last forever, but there’s nothing in today’s update to seriously dent sentiment. In the meantime, STEM has a differentiated strategy, a good balance sheet, and opportunities to drive further growth.

Spectra Systems (LON:SPSY) - strong full year results and multiple growth opportunities going forward. Given the group’s increasing earnings per share and dividend payments over the years, I think the share price probably deserves to be higher. The shares are illiquid and neglected, so perhaps a more engaged investor relations function would help.

Bigblu Broadband (LON:BBB) - an interesting micro cap situation, but one with very poor share price liquidity and an ongoing lack of sustainable cash generation. The company has changed significantly over the past couple of years, so it could be that it’s now a different proposition but, given the lack of liquidity and poor track record over the past five years, I’d need to spend more time on it to really get comfortable with the outlook.


Explanatory notes -

A quick reminder that we don’t recommend any stocks. We aim to review trading updates & results of the day and offer our opinions on them as possible candidates for further research if they interest you. Our opinions will sometimes turn out to be right, and sometimes wrong, because it's anybody's guess what direction market sentiment will take & nobody can predict the future with certainty. We are analysing the company fundamentals, not trying to predict market sentiment.

We stick to companies that have issued news on the day, with market caps up to about £700m. We avoid the smallest, and most speculative companies, and also avoid a few specialist sectors (e.g. natural resources, pharma/biotech).

A key assumption is that readers DYOR (do your own research), and make your own investment decisions. Reader comments are welcomed - please be civil, rational, and include the company name/ticker, otherwise people won't necessarily know what company you are referring to.



Jack’s section

Sthree (LON:STEM)

Share price: 412.5p (pre-open)

Shares in issue: 133,632,112

Market cap: £551.2m

Q1 trading update for the three months to 28 February 2022

SThree is a global pure-play specialist staffing business focused on roles in Science, Technology, Engineering and Mathematics ('STEM').

FYEdG2NqYqKk8k2sNoRfipgGsuQookIcqSX9XprbbJKivTKG9ctq3ktxGN9ZIf_Z0nX5LCOW7_DyfsDobz9pB_RL7xzsrdY-Tf44cCDs1gYpJPIs-4WCeLedfZ0OgrNUKHvMmtdr

Operationally, things have been going well, which you wouldn’t necessarily expect from looking at the share price chart.

4VhLmjyFz_JLPuyiHZo8nFRsiSp-HOHHWsp3uDaKutwvGYxnMiHUGw7yk4ff3KjRX4k4V10Lx9k4jm-ghnt2e6A4DvjAjgcb5P9QmBSR_CM2-3xDK-X9whqf4ASaS4uwFmWDWZe6

This is a good company though, with a positive outlook and reasonable valuation, so it’s worth spending a bit of time on.

Jh4xxKa0VjutX27vBFDoB-xXfZwJaXIaTk7OSkcpZYjyNB74tnouQ0cYD0g8c2MQhuk7e2N2XC6PJriuPASlJYqDDhmNJgF86nkAa4X2yBXV8XZsZX5U-60gsBwT_tTNrW3y0-aW

  • Group net fees for the quarter up 29% year-on-year at constant currency,
  • Strong YoY growth in all five core markets: Germany up 24%, USA up 27%, Netherlands up 45%, UK up 29% and Japan up 78%
  • Momentum across key sectors: Technology up 30%, Life Sciences up 23% and Engineering up 31%
  • Robust balance sheet, with £41m net cash as at 28 February 2022 (28 February 2021: £57m).

The year-on-year decrease in cash is driven by growth in the number of contractors and timing of performance bonuses. The headcount has increased by 2% since Q4 2021 and SThree aims to grow headcount by c. 10% in FY22E.

All geographies and sectors are performing well, with Contract and Permanent YoY net fees up 32% and 18% respectively. Contract now represents 77% of group net fees, up from 75%, and the contractor order book is up 42% YoY (Q4 2021: up 43% YoY).

SThree does say:

As expected, we have seen some normalisation of productivity as new hires come on board although it remains well above historic levels, with Q1 productivity up 19% YoY (FY 2021: up 31%).

It presumably takes time to get new hires up to speed.

Timo Lehne, Interim Chief Executive, commented:

The strong momentum of FY 2021 has continued into the first quarter of FY 2022, in line with the Board's expectations, with robust performances across all our core markets and sectors. In addition, the previously guided investment in our people, talent acquisition and infrastructure to drive long-term sustainable growth is progressing and will gather pace through 2022.

Conclusion

SThree has a strong balance sheet and continues to invest in line with its strategy of focusing on specific niches within sectors and markets where it can gain market share. Investment in talent acquisition remains a priority for the business, and trading is good.

Recruiters are generally doing well at the minute though, so for how long that lasts, and how well the company can lap tougher comps, are questions to consider. Maintaining the present growth rates will become progressively trickier.

But along with Robert Walters (LON:RWA) , SThree presents itself as one of the better picks in the sector and the recent share price drop suggests now could be a good time to take a closer look.


Spectra Systems (LON:SPSY)

Share price: 147p (+5%)

Shares in issue: 45,320,439

Market cap: £66.6m

Results for the 12 months to 31 December 2021

The Spectra Systems share price remains something of an oddity, possibly reflecting a degree of uncertainty around this small cap. Its profitability figures are top drawer, and the group is expanding successfully while maintaining balance sheet strength and paying out a more than 5% dividend yield.

UqgvjJOTEcXXE-15JeXhAN3ngFYwcgY8non9ZCxSdl2-QYHU6UvnygEkCUbKsxks8X2sqgi5SmmODui7hJ_yzjg1b2wm0ft-2A6FKi1FmcnURI4JlYIvOszoImM7j-8xgjJ2TmMr

There’s a real lack of liquidity in the share price though, which might further put investors off. This also puts a slight question mark over the group’s decision to buy back 500,000 shares in the year. It’s more a positive than a negative of course, but managing the liquidity of the shares is also a valid concern for a listed enterprise.

For all the growth in earnings per share over the past few years, the actual share price performance must be frustrating for holders.

qAbqN9cRH-hlbc9LZao_2x99v_mIAdO0zeV2uAHSwME34D5NJq-IKj4Fh3BKmDycs4L0cLARTK5FZcKfwhnnariM0S2pV0HfrZlBdzLGhIQjKeByXXITCQUiUdPhkFAydO7nqycR

  • Revenue +13% to $16.6m,
  • Adjusted EBITDA +8% to $6.9m,
  • Net income up slightly from $5.1m to $5.2m and adjusted earnings per share +1% to 12 cents,
  • Cash from operations +45% to $8.1m.

The thing that jumps out here is the difference between revenue and net income growth. This is due to an increase in tax rate, from 5.6% to 14.8%. Operating profit (EBIT) increased by 10.9%.

Spectra is as busy as it has ever been. In the past year it has executed a contract with its central bank customer relating to the a sensor development program, which has expanded to include the capability to detect exotic counterfeit notes. The group’s agreement for the supply of banknote security materials with this customer has also been extended for another five years.

Our two-decade long relationship with a major world central bank continues to provide new revenues from the introduction of more advanced products. This central bank customer has invested US$8.8MM for the development of these new capabilities which are expected to result in sensor sales of approximately US$50MM from 2024-2026. In addition, we expect a ten-year service agreement worth over US$8MM to line up with the delivery of the first advanced sensors in 2024.
I believe that shareholders should view this spending by our long-standing customer as both a testament to our capabilities for producing cutting edge products, as well as the stability of banknote production by reserve central banks, where the "store of value" is as much a driver for banknote production as every day transactions.

It’s interesting to note that final sentence, given that the rise of cashless transactions is often seen as a big headwind for the business.

Spectra has also attracted a new customer for its materials in K-cups, ‘more than doubling the sales of this product over 2020 levels’. It has also obtained a new customer for its TruBrandTM product in addition to current tobacco related sales in China.

Banknotes - established a vertical integration of polymer banknote substrate manufacturing to produce ready for printing substrates, and commenced a polymer print trial with a Middle Eastern central bank.

The efficacy of the AerisTM banknote cleaning process for deactivating Covid has been validated, with third party testing results showing the deactivation of Covid to below detectable limits. Spectra has also patented its new Banknote Disinfection System and introduced the product to the market with one Asian central bank requesting a price quotation.

Additionally, the group has been selected by one of the largest US lotteries to provide internal control software, expanded this business into Canada with a new contract award, and renewed a long-term US lottery customer contract.

Outlook

The group notes several short and long-term opportunities, which I’ll just quote as there’s a lot. Short-term is expected in the 2022-2024 period and includes:

  • Fulfillment of new, larger than typical pre-Covid-19 orders for covert materials to a long-standing central bank customer during 2022;
  • Additional sensor development funding;
  • Completion of the development of the new generation of sensors for a long-standing central bank customer with US$6.2MM of revenue still to be recognized through 2023;
  • Increased sales of TruBrandTM related products to reach the level of several million dollars per annum in both tobacco and other opportunities such as tax stamps and government documents;
  • Increase the K-cup business to the US$1MM per annum level and beyond;
  • First sales of the newest patent pending phosphour product;
  • Sale of its first banknote cleaning or decontamination system to central banks;
  • Qualification with a central bank of our FusionTM machine-readable polymer substrate;
  • Expansion of gaming software business in Canada and other non-USA customers; and
  • Supply of quality control equipment to a central bank.

Long-term opportunities are expected in the 2024-2028 time frame and include:

  • A supply agreement for its polymer substrate technology (FusionTM) with a major central bank; and
  • Supply of upgraded sensors worth up to US$50MM to a central bank customer.

Conclusion

The curious case of Spectra Systems continues - multiple growth opportunities, a strong balance sheet, progress across all business lines, good returns to shareholders, and yet the share price either flatlines or falls. Perhaps the Spectra Systems management team needs to get out there to explain and de-mystify the company to investors.

There’s certainly a lot of different products, technologies, and business segments at play here, and that’s before we’ve even touched on the group’s more recent strategy of investing in early-stage businesses such as Solaris BioSciences (which looks to have made an increased loss this year).

That’s presently a small part of the whole though. Spectra’s core business is underpinned by its contracts with a major G7 central bank that have spanned two decades. That’s also perhaps a significant risk, should that partnership come to an end for some reason.

It’s worth investigating that possibility in more detail but the duration of the relationship so far is notable, and I continue to view the Spectra share price as slightly anomalous given the growth prospects and dividend track record.


Bigblu Broadband (LON:BBB)

Share price: 50.5p (+5.21%)

Shares in issue: 58,365,678

Market cap: £29.5m

Final results for the year to 30 November 2021

This is a provider of alternative super-fast and ultra-fast broadband services throughout Australasia and the Nordics, which supports consumers and businesses unserved or underserved by fibre.

To provide some context, 2021 was an important year for the group due to the disposal of its majority interest in Quickline (the UK fixed wireless business) to Northleaf. The Disposal valued BBB's shareholding in Quickline at up to £48.6m, representing a return of up to 5.8x the cost of its investment over a three-year period.

The Group received £31.1 million in cash on completion, with up to a further £10.1 million payable as deferred contingent consideration that is subject to certain performance conditions being met by no later than 31 March 2022, or in certain circumstances, 31 May 2022.

So there could be another £10.1m of cash to come soon, if performance conditions are met. However:

As disclosed when the Disposal was announced, the deferred contingent consideration is dependent on achieving certain roll-out and subsidy milestones. Whilst progress is being made in scaling up the organisation in terms of people and systems, the continued global shortage of microchips affecting the supply of 5G radio equipment means that the milestones required to deliver the maximum amount due for the deferred contingent consideration are unlikely to be met in full, partially reducing the amount payable

The cash brought in from disposals has been used to completely pay down debt and return capital to shareholders.

The Board believes that BBB is firmly on the front foot with a strong balance sheet and remains focused on maximising and delivering shareholder value from each of the Company's remaining businesses; Australasian operations (Skymesh Pty Limited) based in Brisbane and the Nordics operations based in Oslo (Bigblu Norge AS) (the "Continuing Group").

Moving on to the key FY21 results, we have:

  • Total revenue +15.8% to £27.1m and like-for-like revenue growth +15.3%,
  • Adjusted EBITDA +11.1% to £4.6m,
  • Adjusted profit after tax increased from £1.1m to £2.5m (with reported profit before tax of £27m including the disposal of Quickline),
  • Adjusted earnings per share increased from 1.9p to 4.3p,
  • Net cash down from £7.4m to £5.2m after full debt repayment of £8.4m and return of capital of £26.1m.

Total customers as at 30 November - 59k (FY20: 57k). Strong organic growth in customer numbers in Australia offset by continued pressure on customer numbers in the Nordics due to exceptional churn relating to the phased demounting of loss-making sites.

Australasia

SkyMesh is the leading Australian satellite broadband service provider, with 50k customers (up from 46k). Total revenues were £21.8m, with adjusted EBITDA of £4.0m.

Having been named Best Satellite NBNCo Provider in 2019, 2020 and again in 2021, SkyMesh continues to secure over 50% market share of net new satellite adds under the NBNCo scheme as demand continues to grow for the Sky Muster Plus product. SkyMesh is seeing growth in the business sector subsequent to the release of a new business focused product by NBNCo and this momentum will continue into 2022.

Partnerships or acquisitions are also being targeted. SkyMesh recently signed an agreement with Kacific to provide services into New Zealand and acquired assets and customers from Clear Networks after the period end.

Nordics

Bigblu Norge's infrastructure upgrade has been completed and unprofitable sites have been dismounted. A distribution agreement with Telenor has been entered to provide next generation ultrafast broadband via wireless 5G, although this is running six months behind due to equipment shortages.

This part of BBB used to deliver strong EBITDA and cash flows but has more recently faced high levels of customer churn due to increased fibre competition and low broadband speeds.

The challenges experienced in the Nordic region in the period saw a reduction in both revenue and adjusted EBITDA. Total revenue from the Nordics for the year ended 30 November 2021 was £4.6m and adjusted EBITDA was £1.9m.

Conclusion

BigBlu is changing shape fast and recent disposals have strengthened the balance sheet, while focusing operations on two potential growth markets. It could be a recipe for success, but I'm mindful of past losses.

The share price performance has been static over the past few years, obscuring the significant changes in capital profile and operating structure.

_Qwsc2OOetV4dslGO5clzWLhJ6GVNDBu8f9K2TMdh8AwZ537TiB4vOIXrfSClBElOzguzsMB6IczEOPcv4sdD0w3idOV3KE7GxlLStHL-Nh3o_uHnVd-DNZ1-W2NDjhrFX6bDMgL

The Nordics business still needs fixing, but progress is being made. Investments and upgrades have improved technology, speeds, and throughput. Meanwhile, the customer base appears to have stabilised and provides ‘a good foundation for the launch of the next generation satellites over the next years’.

The Australasia segment seems to be in good shape. SkyMesh has a strong market position and is growing, there is expansion into New Zealand, and the acquisition of Clear Networks increases focus on the business market and expansion into the fixed wireless market.

It’s potentially a company of interest, and I do note the improving StockRank, but it’s also an illiquid micro cap with a history of losses and cash burn. It could do well from here, but I don’t want to get swept up in the management commentary without acknowledging the poor past performance and the fact that the company has so far struggled to generate cash.

This year sees a net cash outflow from operations of £1.6m with capex spend of just over £6m.

Q9p3tbqcRRSPdnNWWLd-hSbD1vX2q7W1SOQ2RVJl_6LW-ysRiMW0CpJ3jDC3uvJq3NycnOyzqRUt-hpbWWD0XEaKxapXKlP0Xh0dXFrpOGOJa5mbQTh8kdyL66nHhUXYE_BBzcHI



Disclaimer

This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.

50 comments


Avatar for Chris B

As someone who sold Pendragon (LON:PDG) on 8 March at c.20p, it is more than a little annoying to see it rocket to 26p today on this news of a takeover bid from its 25% shareholder, Hedin Group. This bid was 'submitted several weeks ago' and apparently summarily dismissed by the Board, who saw no reason to disclose it to mugs like me. I guess they didn't consider it material!

19
Avatar for mojomogoz

Beeks Financial Cloud (LON:BKS)

I don't know  very well. Looking at it briefly today I'm struck by how cash consumptive growth seems to be, a rather sketchy balance sheet, significant capitalised development cost supporting adjusted profit claims but a highflying valuation nevertheless. Plus there was a cash covenant breach back in December...

Why are investors in a good position at current price to capitalise on any growth they achieve? What exposure does it have reduced trading volume in its markets? Is a capital raise inevitable?

12
Avatar for rmillaree

Beeks Financial Cloud (LON:BKS)

Seems pretty obvious to me that a company like this doubling sales in a 2 year period is going to be splashing the cash at this stage of its growth spurt. Not sure if there are any decent broker notes available that map the future cashflow expectations - that is where I would want to be looking.

Not sure it would be the end of the world if they raised say 8 mill - dilution of 10% ish. So even if they do need to raise funds is that the end of the world?

They state they have already upgraded forecasts for this year 3 times so to me that’s a positive sign that at least they are driving sales forward and presumably their business must be sticky? 

Must admit though I haven’t looked at the numbers In too much detail so your concerns are certainly very sensible questions to be asking to be sure.

3
Avatar for Trident

I think if you look back at previous Spectra Systems (LON:SPSY) presentations on PI World, you will see the CEO address some of the issues.

I am struggling to remember the technical cause of lack of liquidity, but the CEO suggested there was some forthcoming possible news on that front (this was a while back).

I was impressed by the CEO's presentation at the time, but didn't pull the trigger for some reason. Possibly my concerns about liquidity, which I have tried to make a feature of my buying criteria, amongst others, put it in the Watchlist category.

FYI they are registered in Delaware in the USA and are not obligated to follow the Takeover Code if that's of concern to anyone.

4
Avatar for Caper4

I sold the share because of the lack of liquidity.  In today’s market conditions you need to be able to get out fast !!!

1
Avatar for FREng

John Authers' daily email today comments that the VIX volatility index is back below its pre-invasion level.  Maybe that makes it a good protective buy if you think the risk to markets could get much worse yet.

Does anyone here trade VIX? If you do, what tickers do you favour?

5
Avatar for Ben1

I just read the John Authers email. Interesting, but of course it is very America focused. If America is shrugging off the invasion, how much of that is just because Ukraine is a long away from America (most americans probably couldn't tell you where it was on a map), and has probably  dropped off their news feeds. Most of our media attention is on refugees (which aren't going to be affecting America), not on the war itself, where there are no major advances or retreats for them to talk about.

If it did provoke world war 3, the Americans would probably be fashionably late to it anyway!

14
Avatar for planetx

Unbound  feeling generous with its senior team  award nil cost options to  them .

Typical private equity mentality means this moves from watch list to avoid list .

Just plain wrong in my opinion to issue nil cost options,  private equity mentality at its worst spilling over into Aim territory .

Rhymes with tankers .

Why can’t they just be happy with their big fat salaries and if they want to own part of the company write the cheque out like the rest of us have to .

Remember where the Unbound and Hostmore teams came from , private equity and they will be self serving to the end . Avoid these companies even if they seem great value . You 

39
Avatar for Bouden54

Remember that Hotter Shoes and TGI where the 2 companies Electra were struggling for years to shift from their otherwise excellent portfolio when it was wound up - feels a bit like the leftover dross and would personally avoid both. 

10
Avatar for planetx

And on the back of the what 8 million ? Fees that they agreed to pay in the split up .

The more I think about it,  it’s one total royal piss take and what is worse  is they just carry on .

How about simply building a company to be proud of with longevity , for the benefit of its shareholders .

The form is very clear to see now ,  if the market swings up for sure they will do well as anyone can surf a riding ride, but for 100% sure in a tough economy and market you need to be better than these self fulfilling robbing clowns are showing themselves to be .




10
Avatar for rmillaree

Unbound (LON:UBG)

I have had a look at the hurdles that need to be hit and at least they are fairly challenging on face value - if we say company will be doing EPS of 18p and has p/e of ten that will be shareprice of 180p. Thats worth a bonus of 550k IMHO to main bods - if they hit those targets on fair and reasonable lfl basis and shareprice has gone up over fourfold in the meantime from where we are now!! So no dummy spitting from me here unless i am mising something.

Annual Compound Total Shareholder Return percentage ('TSR') over
the three years to the year ending January 2025 (weighting 50%): Vesting will
start from a threshold at 40% pa, with maximum vesting at 70% pa


Earnings Per Share in the Year to January 2025 (weighting 50%):
Vesting will start from a threshold of 18.60 pence per share, with maximum
vesting at 22.74 pence per share

8
Avatar for planetx

What is grossly offensive is the fact they are nil cost .   At the very worst the strike price should be current share price . 

The sense of entitlement is just plain wrong . 

First sign of credible "founder mentality" is actual skin in the game  this is the acid test of a management team with credibility and commitment to the cause of the company and to represent shareholders . 

These clowns are having none of that, they risk nothing of their cash but everything of shareholders who also pay their wages . 

Nil cost options is simple shareholder theft,  these guys would be better off wearing Dick Turpin masks and at least being up front  about their willingness to lay it on the line.

I say this as someone who built a business and every single day I was motivated by representing  my shareholders as well as myself to the best of my ability. 

I find it a total wind up, and on the back of the self serving float and its luxurious "fee fest" there is "form" which means this is not a credible management team to be trusted to represent a shareholder. 

Honestly blows my mind . 

20
Avatar for davidjhill

I don't have a problem with nil cost when the targets are sufficiently challenging, which in this case they are.

Effectively you can think of it as a bonus. Get the share price up to 150-200p and you get £500k . I for one will be very happy at a 200p share price over 2-3 years from here. The directors aren't founders so they do need a sufficient incentive in place and this isn't excessive or unreasonable imo.

I do have major problems with BoDs that issue nil cost without a big hurdle rate. Then I agree it is just a transfer of value from shareholders to Directors. In this case it isn't though.

6
Avatar for planetx

Think we need to agree to disagree !   

The  solution is to issue them at the current share price not nil cost . 

Nil cost is  a freebie at the expense of shareholders and if shareholders consider that "I'm winning as well if they deliver" that is their short sighted choice but I just  dont buy into that way of thinking myself . 

There are lines in life and business and this is over the line, applying the logic that "if they deliver that then who should I worry" misses the point totally . 

Morally bankrupt for me, and on the back of the 8 million fee fest this is now a group of people that are showing signs that the company is there to serve them , and not the other way round . 

Form is there now - avoid like the plague ,. 


11
Avatar for planetx

As a final Ps to this .

I wonder how much cash the senior  gang  at  both Hotter and  TGI. Fridays amanaged to extract to enrich themselves out of the  “uncoupling”  (if any but I suspect they had their fingers in the honeypot  again ) 

If they did that would make it a triple whammy !!  



0
Avatar for Zipmanpeter

Re  £UBG nil cost share awards for BOD if they achieve targets.   It's worth going back to the objectives: to incentivise/retain the BOD for their 'special skills' and align them with shareholders (or more accurately prevent them manipulating the share price to their advantage

On this basis, the award of of options make sense for shareholders if you agree that the BOD should be paid as much as their salary plus what they earn as a bonus.  (We can argue why the BOD should not be working flat out for their base salary, I don't recall bonuses making me work harder, but that is another discussion!).

Target related share options delay cash out for the business and are not paid in cash, both helpful for a growing business.  I agree nil cost feels wrong

What would be even better would be to pay say 10% of their base salary as shares at the market price until they have at least 1x base salary - that's continuous, real alignment!

0
Avatar for TamzinXPiworld

Emis (LON:EMIS) FY21 results presentation to analysts: video.  Revenue +6%.  Adjusted operating margin 25.9% +125bps.  Adjusted EPS+10%.  Dividend +10%.  27 customers are using the EMIS X Analytics. EMIS X is where the future of this really lies IMO.  Well positioned for 2022.  

Webinars forthcoming over the next few weeks, register for any of them here:

Pebble (LON:PEBB) Full Year 2021 results: Thursday 24th March, 1pm

Personal Group (LON:PGH) Full Year 2021 results: Friday 1st April, 12 noon

Property Franchise (LON:TPFG) Full Year 2021 results: Wednesday 6th April, 12.30pm

Tracsis (LON:TRCS) Interim results: Friday 8th April, 1pm

And, the Stockopedi/PIWORLD StockSlam: Wednesday 6th April, 6pm. Where private investors 'slam' their best stock idea in 3 minutes, followed by Q&A. We still have a couple of places left if you'd like to pitch your favourite stock. This may be your last chance since we'll be taking a break with the StockSlam events after this one. To take part contact me here. Or, register to attend live, here.

10
Avatar for truegent

why do you put the time out of interest ? e.g. for TPFG you have put 12:30pm...

[edit - ive just realised its the time for the webinar, i thought it was for the actual results - my bad !]

0
Avatar for Funnymoney

Is anyone else fed up with the "Net Asset Value" announcements which now infect the news feed?  I think the main news feed should be actual announcements rather than "price monitoring extensions" "stabilisation notices" etc.  

15
Avatar for unwise2

Another undisclosed takeover bid, made "a few weeks ago".

https://cardealermagazine.co.u...

8
Avatar for Aislabie

I also hold and like Spectra Systems but I am increasingly concerned by the massive concentration of sales. In the last annual report it was noted that 63% of revenue came from just two customers. I had expected that, with the supposed technology advantages of Spectra Systems, there would by now be a rising bunch of happy customers. But there aren’t, and it does not seem to have changed in the last few years. 
If I am getting this wrong I hope someone can allay my fears

8
Avatar for simoan

I also hold and like Spectra Systems but I am increasingly concerned by the massive concentration of sales. In the last annual report it was noted that 63% of revenue came from just two customers. I had expected that, with the supposed technology advantages of Spectra Systems, there would by now be a rising bunch of happy customers. But there aren’t, and it does not seem to have changed in the last few years.

This is a risk with many smaller companies when you look under the bonnet but maybe not to the extent of customer concentration of Spectra Systems (LON:SPSY) So whilst it didn't stop me investing,  that and the poor liquidity means the maximum position size is much less than I would normally consider for a more liquid and diversified business with the same quality metrics and 5% plus dividend yield e.g. Somero Enterprises Inc (LON:SOM)

All the best, Si   

9
Avatar for Aislabie

Thank you Si for your thoughts on Spectra and thanks to Paul for his review.

One other really odd thing about Spectra is that they never hold an AGM because there are never enough votes for a quorum. Even though AGMs have been enfeebled over the years this looks like  something which should draw some reprimand and maybe a quiet word from their Nomad.  Of course holding it in Providence, Rhode Island helps to keep it exclusive even if they get the votes for a quorum!

1
Avatar for Trident

Good point. I think this  was an issue the CEO said was under review in one of their PI World presentations, but possibly said before Covid fully hit? 

I suppose if you have a Delaware registered company, and an AIM listed stock it will always be a bit of a peculiarity. I can understand not wanting to be unduly burdened by certain factors (tax and governance codes, and tight regulation), and just put performance front and centre. But it does make it rely heavily on the good faith actions of the board, and institutions and private investors may be more than usually wary?

The CEO seemed from the presentation to be a reasonable sort, and the Company has been a relatively good performer in terms of revenues and profit. I may revisit their old presentation. They must  be due for a further presentation?

0
Avatar for john2

There was what I thought a very impressive presentation from the Spectra CEO at an online Mello a few months ago.

0
Avatar for skyvan

sthree. "ongoing investment in headcount". English translation please.

2
Avatar for Silver Moon

How about "expanding payroll"?

2
Avatar for Jeffvshepherd

They are taking on more staff.

3
Avatar for JimMcLad

Angle (LON:AGL)

With credit to Bermuda on the relevant ADVFN board :

Conclusions: Isolating CTCs from longitudinally collected PBMCs using an unbiased selection strategy can offer a wider range of retrospective genomic/phenotypic analyses to guide patients' personalized therapy, paving the way for sample sharing in multicenter studies.

https://pubmed.ncbi.nlm.nih.gov/35304611/

5
Avatar for Funnymoney

  Hi Jim, am I right in thinking Angle Angle (LON:AGL) has had a long wait for FDA acceptance, or am I miss-remembering?

1
Avatar for JohnEustace

Yes Funnymoney, Angle (LON:AGL) have been waiting a very long time. Could be due to Covid workload at the FDA as stated but my cynical side suspects the fact that this product could disrupt some US interests may also be involved. 

I am sceptical of all the FxA organisations , e.g. FAA/ Boeing and the FDA itself with the controversy  around their approval of aducanumab for Alzheimers.  They seem to have mixed objectives to promote US business as well as being regulators. 

I'm waiting impatiently to be proved wrong eventually with Angle when they get approval.

6
Avatar for Funnymoney

Thanks John, I was thinking of  Polarean Imaging (LON:POLX) when I asked the question, which is both  UK listed and has seemingly ground breaking innovation (rather oddly there aren't any safety issues at all for them to reject). I don't own either of these stocks yet, but I  am trying to find out about US stocks which are also held up for an inordinate length of time.  It would be get an understanding of whether this is a partisan issue or generalised issue. If the latter then the UK stocks might have hidden value.

1
Avatar for JimMcLad

Funneymoney & John

Yes, the believers are still waiting and the latest date is now Q1/22. The FDA dept that deals with medical devices was snowed under with Covid related fast-track work. Angle is not the only company affected.

There are conspiracy theories re FDA biases which may or may not have some truth in them. It’s also often pointed out that some US pharmas are against Parsortix but few mention that large insurers (Worldwide) will be massively in favour.

The CEO of Angle has said that the last few questions were related to work downstream from the device itself. That coupled with the mass of research papers published by top cancer research labs makes me feel approval is inevitable.

4
Avatar for sheeza

Rua Life Sciences (LON:RUA) might be another one - the company expected to report on discussions with the FDA in January. Nothing has come up yet. Hopefully, the results of the discussions are not so demanding that the Board don't want to tell us while they scratch around for money - as the declining shareprice suggests.

1
Avatar for jonno

Another contract for Avingtrans (LON:AVG) to add to the two recently announced; $4.1m for its American subsidiary Energy Steel.  Last week Avingtrans (LON:AVG) announced a multi-million $ contract in France for Energy Steel and a £6m contract for Booths Industries.  The company appears to be  enjoying strong tailwinds. Also it is notable that the share price has been very stable during the recent turmoil.

Also as mentioned earlier, steady results from Spectra Systems (LON:SPSY) No debt, cash rich and a handsome dividend. Lots of moving parts and not overly easy to get ones head around, hence I suspect the underappreciated share price.

I hold both.

10
Avatar for Brookeda

Beeks Financial Cloud (LON:BKS) announced their final year results today with previous guidance making it more of a formality. Revenue was up 46% with all the additional revenue being pumped back into the business to improve both their global coverage and new product design.  Another 10% of new deals have been signed in the two months to February and they continue to sound very bullish on signing up more deal.

I continue to hold and see this company being much bigger than it is today in 3-5 years time if (and I believe its a big if) they don't get picked up by someone in the meantime.

19
Avatar for davidjhill

Yes strong results from Beeks Financial Cloud (LON:BKS) and a new product in Exchange Cloud coming too, which could also be a winner. The key to investing the profits back into the business at the moment is that revenues have a strong ARR component to them. Thus next year and the year after should see very big uplifts in profitability. The other thing to note is momentum. When dealing with tier 1 institutions momentum is important. Once a few come on board the credibility levels go up significantly and financial institutions will cluster (safety in numbers). Makes it much harder for someone else to come in and start taking the business so provides something of a moat.

Personally I'd be surprised if they are not taken out by a large industry player in due course but hopefully not until they are much bigger.

17
Avatar for Camtab

You know David this is one of those shares which causes me angst. I agree its got some great characteristics, not the least of which an entrepreneurial CEO who holds a good stake. It is just the valuation that holds me back. I have been in, but that was more carefree times and I can't help but feel those times won't be back any time soon. Just my view. A PEG Ratio of over 3 times suggests they have a lot to do.

15
Avatar for davidjhill

I disagree Camtab. You need to look through one years worth of numbers where investment is heavy because they've found a sweet spot that is underserved in the cloud market. 

I reckon ARR should exceed £25m within 12 months from current run rate of £17.7m. They can do 40%+ ebitda margins on that and thus generate £10m of ebitda profit. Depreciation is relatively low as they don't capitalise a lot so that should translate to PBT of circa £7.5m against a market cap of £81m or roughly10* PBT. For this type of business a take out would be more like 25-30* 

I'm not saying it will definitely get there but if you just focus on todays numbers and not 12-24 months forward you're missing where the real value of this business lies. 

4
Avatar for BnB

Hi Paul

I wonder if you’re covering Sthree (LON:STEM) this morning. In response to your reply to my post of Friday, I will try to watch the Empresaria (LON:EMR) webinar. Even “experts” can keep learning and investment is a brutally humbling learning experience, as I know to my cost. Unfortunately for those so inclined, my latest endorsement of Sthree (LON:STEM) comes potentially too late for action as this morning’s strong trading update piles too rapidly on my recommendation. But quick movers might get some alpha before retail investors wake up. Or the market could remain oblivious. Who knows!

It’s probably important to draw a distinction between my investing style and those of more value-oriented investors in relation to the recruitment sector. For the latter, the constituents are probably only worth buying at the bottom of downturns or after market shocks, such as we are experiencing today. For long term buy and holders, like me, then it is all about quality of market position in growth sectors, experienced consultants and the most attractive clients. And here, only Sthree (LON:STEM) & Robert Walters (LON:RWA), that we both like, consistently and predictably deliver.

It’s my wife’s birthday today so I won't get the chance to review Empresaria (LON:EMR) very soon but I will do my best to get on it. I have met the board in the recent past and was less than impressed by the personnel and their growth strategy. I found it hard to imagine how they could profitably develop their brand while keeping their rainmakers committed. So far, the figures bear me out. But new management and good strategy can bring change about so I owe it to us both to dig further.


14
Avatar for Revs8

Photo-me International (LON:PHTM) (I hold) results are positive. After the shenanigans of the rejected offer the share price has dropped and may be a buying opportunity in my opinion.
The company is diversifying away from just photo booths with Wash.ME and Feed.ME well as Photo.ME. 
CEO claims return to pre pandemic revenue. 

8
Avatar for TheFloatingInvestor

Bought back in Friday, after selling a few months back during that offer mess up IMO.....l like the ME brand focus and have used the washing machines a few times,

3
Avatar for planetx

Agree Photo Me looks to be a money making machine with cash in  the bank  to boot .  It is lowly rated as it’s perceived as declining market but they do seem to be coming out with interesting new tweaks evolving photo booths into beauty / laundry .

No wonder the incumbent majority tried  to nick it on the cheap . 

6
Avatar for TheFloatingInvestor

I wonder if he ever really wanted it as the offer was so crap, never going to go through.

5
Avatar for wolfspirit

Sthree (LON:STEM) look like good TU today but the shares have been unloved for the last 6 months.

5
Avatar for TheFloatingInvestor

I notice a number of recruiters seem out of favour ATM...I guess you shouldn't try to fight a trend.

3
Avatar for Bouden54

Very tight labour market, high quits rate and strong pay rises - all very positive for recruitment sector and Sthree (LON:STEM) is pick of the bunch. 

6
Avatar for john2

A solid but not spectacular set of results from Spectra Systems (LON:SPSY) this morning. Future orders look promising.

18
Avatar for Camtab

I love this company. Good yield, strong balance sheet and high margins. What's not to love. Entrepreneurial. Has a price roof around £1.60 for now but frankly they  are niche and seem to have a moat so I can wait for things to move on from here. I am an enthusiastic holder if you haven't already guessed.

8
Avatar for OldSchool05

Spectra Systems (LON:SPSY) is a top holding for me.  There was a couple of excellent broker notes on Research Tree last year which illustrated the high level of visibility of incremental revenue streams over the next 5 years (from central bank contract renewal).  Plus there are a number of material opportunities, any of which could make a big difference to the profitability of the business (Fusion polymer, Trubrand etc).

7
Get the free newsletter